Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cediranib versus placebo added to cisplatin + gemcitabine for advanced biliary tract cancer
2009-013408-30Phase 2Completed
- Sponsor
- University College London
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in biliary cancer, gallbladder cancer, cholangiocarcinoma (CCA) and 1 more comparing Cediranib + cisplatin + gemcitabine with Placebo + cisplatin + gemcitabine (2 arms). Primary endpoint: Progression-free survival. Started Jul 2010; status: completed.
02
Drugs
cediranib
03
Conditions
biliary cancergallbladder cancercholangiocarcinoma (CCA)Ampullary cancer (AC)
Beyond the preview
Go deeper on 2009-013408-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013408-30.